Scinai Immunotherapeutics Announces $4.0 Million Financing Through Private Placement and Warrant Inducement
Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) entered into a securities purchase agreement with an existing life sciences institutional investor for a private placement of 2,458,334 American Depositary Shares (ADSs) (or pre-funded warrants in lieu thereof) together with Series A-1 warrants to purchase up to 3,687,501 ADSs at a $1.20 per ADS exercise price, at a combined purchase price of $1.20 per ADS and accompanying warrants. The Company also entered into a warrant inducement agreement with the same investor f...
Read source-backed brief